QUOTED. Aug. 10, 2018. Ted Davis.
Active Implants is ramping up for a 2019 commercial launch of its NUsurface polycarbonate-urethane meniscus implant as it continues clinical trials in the US. The firm hopes to earn US approval for the device by the end of 2020. See what Active Implants CEO Ted Davis said about it here.
"We've been really focused on collecting data to get to more global approvals, [and] our focus for the last several years has been on the US trial and all the efforts there. Beginning in 2019 our goal is to do some limited commercial release, working with the current sites where we did our clinical work in Europe, before coming to the US." –Ted Davis, CEO, Active Implants LLCClick here for a free trial of Medtech Insight